Expertise in
9
conditions

Dr. Sharmilan Thanendrarajan

Hematology | Oncology
Uams Sats Program
4301 W Markham St, 
Little Rock, AR 
Offers Telehealth
Expertise in
9
conditions
Uams Sats Program
4301 W Markham St, 
Little Rock, AR 

Overview

Sharmilan Thanendrarajan is a Hematologist and an Oncologist practicing medicine in Little Rock, Arkansas.

Dr. Thanendrarajan is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 103 peer reviewed articles and participating in 4 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in AR

Hospital Affiliations

University Of Arkansas Medical Sciences

Languages Spoken

English
German

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Uams Sats Program
4301 W Markham St, Little Rock, AR 72205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host-Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance
Enrollment Status: Terminated
Publish Date: June 22, 2021
Intervention Type: Drug, Device
Study Drug: MEL-CFZ-TD-PACE
Study Phase: Phase 2
Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment Relapsed/Refractory Multiple Myeloma Patients
Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment Relapsed/Refractory Multiple Myeloma Patients
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
UARK 2010-35, A Phase II Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
Enrollment Status: Completed
Publish Date: May 19, 2017
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
Enrollment Status: Withdrawn
Publish Date: January 23, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

103 Total Publications

Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.
Journal: Blood cancer journal
Published: August 07, 2026
Similar Doctors
Expertise in
7
conditions
Dr. Jason E. Farrar
Hematology | Oncology
Expertise in
7
conditions
Dr. Jason E. Farrar
Hematology | Oncology
Referral may be required

Uams Sats Program

4301 W Markham St, 
Little Rock, AR 
 (0.1 miles away)
501-686-5140
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jason Farrar is a Hematologist and an Oncologist practicing medicine in Little Rock, Arkansas. Dr. Farrar is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Pure Red Cell Aplasia, Aplastic Anemia, Childhood Acute Myeloid Leukemia, and Transient Erythroblastopenia of Childhood. Dr. Farrar is currently accepting new patients.

Expertise in
30
conditions
Dr. Frits Van Rhee
Hematology | Oncology
Expertise in
30
conditions
Dr. Frits Van Rhee
Hematology | Oncology
Referral may be required

Uams Sats Program

4301 W Markham St, 
Little Rock, AR 
 (0.1 miles away)
501-686-8000
Languages Spoken:
English, Dutch
See accepted insurances
Accepting New Patients
Offers Telehealth

Frits Van Rhee is a Hematologist and an Oncologist practicing medicine in Little Rock, Arkansas. Dr. Van Rhee is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Van Rhee is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Uams Sats Program

4301 W Markham St, 
Little Rock, AR 
 (0.1 miles away)
501-686-8230
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

Maurizio Zangari is a Hematologist practicing medicine in Little Rock, Arkansas. Dr. Zangari is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Zangari is currently accepting new patients.

Frequently Asked Questions about Dr. Sharmilan Thanendrarajan

How do I make an appointment with Dr. Sharmilan Thanendrarajan?

You can book an appointment with Dr. Sharmilan Thanendrarajan by calling their office at 501-526-6990. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sharmilan Thanendrarajan a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sharmilan Thanendrarajan is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sharmilan Thanendrarajan specialize in?

While Dr. Sharmilan Thanendrarajan is a Hematology, they have specific expertise in Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Sharmilan Thanendrarajan participate in research or clinical trials?

Yes. Dr. Sharmilan Thanendrarajan has published 103 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Sharmilan Thanendrarajan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sharmilan Thanendrarajan accept my insurance?

Dr. Sharmilan Thanendrarajan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 501-526-6990 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thanendrarajan's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile